Mark Throsby

4.6k total citations · 2 hit papers
46 papers, 3.3k citations indexed

About

Mark Throsby is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Mark Throsby has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Mark Throsby's work include Monoclonal and Polyclonal Antibodies Research (23 papers), Glycosylation and Glycoproteins Research (9 papers) and HER2/EGFR in Cancer Research (9 papers). Mark Throsby is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), Glycosylation and Glycoproteins Research (9 papers) and HER2/EGFR in Cancer Research (9 papers). Mark Throsby collaborates with scholars based in Netherlands, France and United States. Mark Throsby's co-authors include Jaap Goudsmit, Mandy Jongeneelen, Marc‐André Elsliger, Damian C. Ekiert, Gira Bhabha, Ian A. Wilson, Robert H. Friesen, John de Kruif, Jan ter Meulen and Mireille Dardenne and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Throsby

46 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

2009 1.0k citations Damian C. Ekiert, Gira Bhabha et al. Science profile →
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

2008 596 citations Mark Throsby, Mandy Jongeneelen et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Throsby Netherlands	23	1.5k	985	871	813	774	46	3.3k
Toshiaki Maruyama Japan	23	2.0k 1.3×	650 0.7×	783 0.9×	768 0.9×	742 1.0×	62	3.9k
Marcus Dorner United States	24	1.1k 0.8×	596 0.6×	419 0.5×	319 0.4×	417 0.5×	43	2.5k
Zhongyu Zhu United States	33	1.0k 0.7×	722 0.7×	1.3k 1.5×	929 1.1×	1.0k 1.3×	85	3.5k
Chantal Rabourdin‐Combe France	39	1.8k 1.2×	2.7k 2.7×	1.4k 1.7×	443 0.5×	734 0.9×	94	5.0k
Óscar R. Burrone Italy	41	659 0.4×	1.1k 1.1×	1.4k 1.6×	754 0.9×	1.6k 2.1×	150	4.9k
Anette Stryhn Denmark	25	472 0.3×	1.4k 1.4×	1.3k 1.5×	522 0.6×	556 0.7×	61	2.8k
Joshy Jacob United States	33	1.1k 0.8×	4.3k 4.3×	1.3k 1.4×	909 1.1×	533 0.7×	60	5.9k
Jason P. Gardner United States	22	537 0.4×	734 0.7×	600 0.7×	309 0.4×	290 0.4×	33	2.1k
Piero Pileri Italy	19	1.7k 1.2×	768 0.8×	619 0.7×	787 1.0×	412 0.5×	29	3.7k
Leonard Moise United States	33	543 0.4×	1.1k 1.1×	1.5k 1.8×	774 1.0×	453 0.6×	99	2.7k

Countries citing papers authored by Mark Throsby

Since Specialization

Citations

This map shows the geographic impact of Mark Throsby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Throsby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Throsby more than expected).

Fields of papers citing papers by Mark Throsby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Throsby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Throsby. The network helps show where Mark Throsby may publish in the future.

Co-authorship network of co-authors of Mark Throsby

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Throsby. A scholar is included among the top collaborators of Mark Throsby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Throsby. Mark Throsby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2021). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 39(8). 1163–1164. 2 indexed citations

Deshière, Alexandre, Martijn van Rosmalen, Christian Wohn, et al.. (2021). Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP. Cancer Research. 81(13_Supplement). 952–952. 5 indexed citations

Loo, Pieter Fokko van, Basav N. Hangalapura, Soley Thordardottir, et al.. (2019). MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis. Expert Opinion on Biological Therapy. 19(7). 721–733. 47 indexed citations

Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2018). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 33(5). 922–936.e10. 84 indexed citations

Roovers, Rob C., Bram Herpers, Mark I. James, et al.. (2017). Abstract 32: Preclinical evaluation of MCLA-158: A bispecific antibody targeting LGR5 and EGFR using patient-derived colon carcinoma organoids. Cancer Research. 77(13_Supplement). 32–32. 4 indexed citations

Leto, Simonetta M., Francesco Sassi, Valter Torri, et al.. (2015). Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2 -Amplified Gastrointestinal Carcinomas. Clinical Cancer Research. 21(24). 5519–5531. 76 indexed citations

Lee, David W., Dirk M. Zajonc, Rena R. Xian, et al.. (2012). Phage display generation of a novel human anti‐CD1A monoclonal antibody with potent cytolytic activity. British Journal of Haematology. 159(3). 299–310. 8 indexed citations

Kruif, John de, et al.. (2010). Generation of stable cell clones expressing mixtures of human antibodies. Biotechnology and Bioengineering. 106(5). 741–750. 29 indexed citations

Ekiert, Damian C., Gira Bhabha, Marc‐André Elsliger, et al.. (2009). Antibody Recognition of a Highly Conserved Influenza Virus Epitope. Science. 324(5924). 246–251. 1048 indexed citations breakdown →

10.

Throsby, Mark & John de Kruif. (2009). Construction of Phage Antibody Repertoires from the Blood of West Nile Virus-Infected Donors. Methods in molecular biology. 562. 45–60. 1 indexed citations

11.

Kruif, John de, Arjen Kramer, Therèse Visser, et al.. (2009). Human Immunoglobulin Repertoires against Tetanus Toxoid Contain a Large and Diverse Fraction of High-Affinity Promiscuous VH Genes. Journal of Molecular Biology. 387(3). 548–558. 19 indexed citations

12.

Throsby, Mark, Mandy Jongeneelen, Leo L. M. Poon, et al.. (2008). Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells. PLoS ONE. 3(12). e3942–e3942. 596 indexed citations breakdown →

13.

Throsby, Mark, Cecile Geuijen, Jaap Goudsmit, et al.. (2006). Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus. Journal of Virology. 80(14). 6982–6992. 135 indexed citations

14.

Cox, Freek, Pauline M.L. Rood, Mark Throsby, et al.. (2005). Affinity ranking of antibodies using flow cytometry: Application in antibody phage display-based target discovery. Journal of Immunological Methods. 302(1-2). 68–77. 24 indexed citations

15.

Bijl, Nora, Freek Cox, Mark Throsby, et al.. (2004). A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry. European Journal of Cancer. 41(1). 178–187. 50 indexed citations

16.

Throsby, Mark, André Herbelin, Jean‐Marie Pléau, & Mireille Dardenne. (2000). CD11c+ Eosinophils in the Murine Thymus: Developmental Regulation and Recruitment upon MHC Class I-Restricted Thymocyte Deletion. The Journal of Immunology. 165(4). 1965–1975. 97 indexed citations

17.

Amrani, Abdelaziz, Sylvie Durant, Mark Throsby, et al.. (1998). Glucose Homeostasis in the Nonobese Diabetic Mouse at the Prediabetic Stage¹. Endocrinology. 139(3). 1115–1124. 58 indexed citations

18.

Saravia, Flavia, Christelle Faveeuw, Marcel Tappaz, et al.. (1996). Localization of gamma-aminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse.. Endocrinology. 137(8). 3497–3506. 25 indexed citations

19.

Throsby, Mark, Zhiyu Yang, David Copolov, & Alan T. Lim. (1994). Colocalization of atrial natriuretic factor and β-endorphin in rat thymic macrophages. Peptides. 15(2). 291–296. 2 indexed citations

20.

Throsby, Mark, Dan Lee, Weiqing Huang, et al.. (1991). Evidence for Atrial Natriuretic Peptide-(5–28) Production by Macrophages of the Rat Spleen: An Immunochemical and Nonradioactivein SituHybridization Approach*. Endocrinology. 129(2). 991–1000. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact